Crane NXT, Co. - Quarter Report: 2015 March (Form 10-Q)

(check one):

Large accelerated filer

Accelerated filer

Non-accelerated filer

o (Do not check if a smaller reporting company)

Smaller reporting company

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

Mark One:



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2015



o	TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from to

Commission File Number: 1-1657

CRANE CO.

(Exact name of registrant as specified in its charter)




Delaware		13-1952290
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)



100 First Stamford Place, Stamford, CT		06902
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: 203-363-7300

(Not Applicable)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non –accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The number of shares outstanding of the issuer’s classes of common stock, as of April 30, 2015

Common stock, $1.00 Par Value – 57,998,140 shares

PART I: FINANCIAL INFORMATION

ITEM 1: FINANCIAL STATEMENTS

CRANE CO. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(IN MILLIONS, EXCEPT PER SHARE DATA)

(UNAUDITED)



	Three Months Ended
	March 31,
	2015			2014
Net sales	$	678.8		$	716.8
Operating costs and expenses:
Cost of sales	442.0			462.7
Selling, general and administrative	148.6			157.9
Restructuring charges	0.5			10.0
Acquisition integration related charges	1.6			4.7
Operating profit	86.0			81.4
Other income (expense):
Interest income	0.5			0.4
Interest expense	(9.9		)	(9.8		)
Miscellaneous - net	(0.3		)	(0.2		)
	(9.7		)	(9.6		)
Income before income taxes	76.3			71.8
Provision for income taxes	24.9			22.9
Net income before allocation to noncontrolling interests	51.3			48.9
Less: Noncontrolling interest in subsidiaries’ earnings	0.3			0.2
Net income attributable to common shareholders	$	51.1		$	48.7
Earnings per basic share	$	0.88		$	0.83
Earnings per diluted share	$	0.87		$	0.82
Average basic shares outstanding	58.1			58.5
Average diluted shares outstanding	58.9			59.5
Dividends per share	$	0.33		$	0.30

See Notes to Condensed Consolidated Financial Statements

Page 2

CRANE CO. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(IN MILLIONS)

(UNAUDITED)



	Three Months Ended
	March 31,
	2015			2014
Net income before allocation to noncontrolling interests	$	51.3		$	48.9
Other comprehensive (loss) income, net of tax
Currency translation adjustment	(70.9		)	(2.5		)
Changes in pension and postretirement plan assets and benefit obligation, net of tax	2.0			1.5
Other comprehensive (loss) income	(68.9		)	(1.0		)
Comprehensive (loss) income before allocation to noncontrolling interests	(17.6		)	47.8
Less: Noncontrolling interests in comprehensive (loss) income	0.1			0.2
Comprehensive (loss) income attributable to common shareholders	$	(17.7	)	$	47.7

See Notes to Condensed Consolidated Financial Statements.

Page 3

CRANE CO. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN MILLIONS)

(UNAUDITED)



	March 31, 2015		December 31, 2014
Assets
Current assets:
Cash and cash equivalents	$	296.9	$	346.3
Accounts receivable, net	436.2		410.9
Current insurance receivable - asbestos	20.5		20.5
Inventories, net:
Finished goods	115.1		111.8
Finished parts and subassemblies	45.3		42.5
Work in process	58.9		53.2
Raw materials	158.3		162.2
Inventories, net	377.6		369.7
Current deferred tax asset	33.1		33.0
Other current assets	18.4		14.8
Total current assets	1,182.7		1,195.2
Property, plant and equipment:
Cost	804.6		824.9
Less: accumulated depreciation	523.4		534.7
Property, plant and equipment, net	281.1		290.3
Long-term insurance receivable - asbestos	123.8		126.8
Long-term deferred tax assets	189.2		196.2
Other assets	95.1		97.6
Intangible assets, net	341.3		353.5
Goodwill	1,174.0		1,191.3
Total assets	$	3,387.3	$	3,450.8

See Notes to Condensed Consolidated Financial Statements.

Page 4

CRANE CO. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN MILLIONS, EXCEPT SHARE AND PER SHARE DATA)

(UNAUDITED)



	March 31, 2015			December 31, 2014
Liabilities and equity
Current liabilities:
Short-term borrowings	$	127.5		$	100.8
Accounts payable	210.7			228.8
Current asbestos liability	79.0			79.0
Accrued liabilities	228.5			225.8
U.S. and foreign taxes on income	15.9			5.6
Total current liabilities	661.6			640.0
Long-term debt	749.2			749.2
Accrued pension and postretirement benefits	268.0			278.3
Long-term deferred tax liability	43.0			46.3
Long-term asbestos liability	520.9			534.5
Other liabilities	122.4			131.9
Total liabilities	2,365.1			2,380.2
Commitments and contingencies (Note 8)
Equity:
Preferred shares, par value $.01; 5,000,000 shares authorized	—			—
Common stock, par value $1.00; 200,000,000 shares authorized, 72,426,139 shares issued	72.4			72.4
Capital surplus	249.4			249.2
Retained earnings	1,553.9			1,522.0
Accumulated other comprehensive loss	(367.5		)	(298.8		)
Treasury stock	(496.9		)	(485.1		)
Total shareholders’ equity	1,011.4			1,059.8
Noncontrolling interests	10.9			10.8
Total equity	1,022.3			1,070.6
Total liabilities and equity	$	3,387.3		$	3,450.8

Common stock issued	72,426.1			72,426.1
Less: Common stock held in treasury	(14,434.2		)	(14,304.3		)
Common stock outstanding	57,991.9			58,121.8

See Notes to Condensed Consolidated Financial Statements.

Page 5

CRANE CO. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN MILLIONS)

(UNAUDITED)



	Three Months Ended
	March 31,
	2015			2014
Operating activities:
Net income attributable to common shareholders	$	51.1		$	48.7
Noncontrolling interests in subsidiaries’ earnings	0.3			0.2
Net income before allocation to noncontrolling interests	51.3			48.9
Restructuring - non-cash	0.2			0.4
Depreciation and amortization	16.5			21.8
Stock-based compensation expense	5.8			5.6
Defined benefit plans and postretirement (benefit) expense	(1.6		)	(2.9		)
Deferred income taxes	4.3			4.7
Cash used for working capital	(57.1		)	(69.3		)
Defined benefit plans and postretirement contributions	(3.0		)	(4.8		)
Environmental payments, net of reimbursements	(4.1		)	(2.7		)
Payments for asbestos-related fees and costs, net of insurance recoveries	(10.7		)	(12.9		)
Other	(13.4		)	(7.7		)
Total used for operating activities	(11.6		)	(18.9		)
Investing activities:
Capital expenditures	(10.2		)	(9.4		)
Proceeds from disposition of capital assets	1.4			0.2
Total used for investing activities	(8.8		)	(9.2		)
Financing activities:
Equity:
Dividends paid	(19.1		)	(17.6		)
Reacquisition of shares on open market	(25.0		)	—
Stock options exercised - net of shares reacquired	6.7			3.8
Excess tax benefit from stock-based compensation	0.9			5.1
Debt:
Proceeds from (repayment of) credit facility	(100.0		)	18.0
Proceeds from issuance of commercial paper	126.7			—
Total (used for) provided by financing activities	(9.9		)	9.3
Effect of exchange rates on cash and cash equivalents	(19.0		)	(1.6		)
Decrease in cash and cash equivalents	(49.3		)	(20.4		)
Cash and cash equivalents at beginning of period	346.3			270.6
Cash and cash equivalents at end of period	$	296.9		$	250.3
Detail of cash used for working capital:
Accounts receivable	$	(37.9	)	$	(17.4	)
Inventories	(20.2		)	(22.1		)
Other current assets	(4.0		)	(1.4		)
Accounts payable	(12.7		)	(15.1		)
Accrued liabilities	8.5			(14.2		)
U.S. and foreign taxes on income	9.2			0.8
Total	$	(57.1	)	$	(69.3	)
Supplemental disclosure of cash flow information:
Interest paid	$	1.5		$	1.6
Income taxes paid	$	7.7		$	12.2

See Notes to Condensed Consolidated Financial Statements.

Page 6

Note 1 - Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and, therefore, reflect all adjustments which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. These interim condensed consolidated financial statements should be read in conjunction with the Consolidated Financial Statements and Notes to Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

Recent Accounting Pronouncements

In April 2015, the Financial Accounting Standards Board ("FASB") issued amended guidance to simplify the presentation of debt issuance costs. The amended guidance requires debt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The amendment is effective for periods beginning after December 15, 2015, with early adoption permitted. The Company does not expect the amended guidance to have a material impact on its financial statements.

In January 2015, the FASB issued amended guidance to eliminate the concept of extraordinary items from U.S. GAAP to simplify income statement classification. Under the existing guidance, an entity is required to separately disclose extraordinary items, net of tax, in the income statement after income from continuing operations if an event or transaction is of an unusual nature and occurs infrequently. This separate, net-of-tax presentation (and corresponding earnings per share impact) will no longer be allowed. The amendment is effective for periods beginning after December 15, 2015, with early adoption permitted. The Company does not expect the amended guidance to have a material impact on its financial statements.

In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all current industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. In April 2015, the FASB agreed to propose a one-year deferral of the effective date. If the proposed deferral is approved, the new standard is effective for reporting periods beginning after December 15, 2017, including interim periods within that reporting period. The new standard can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company is evaluating the impact of adopting this new accounting standard on its financial statements, as well as its plans for the timing and means of adoption.

Note 2 - Segment Results

The Company’s segments are reported on the same basis used internally for evaluating performance and for allocating resources. The Company has four reportable segments: Fluid Handling, Payment & Merchandising Technologies, Aerospace & Electronics and Engineered Materials. Assets of the reportable segments exclude general corporate assets, which principally consist of cash, deferred tax assets, insurance receivables, certain property, plant and equipment, and certain other assets. Furthermore, Corporate consists of corporate office expenses including compensation, benefits, occupancy, depreciation, and other administrative costs.

Page 7

Financial information by reportable segment is set forth below:



	Three Months Ended
	March 31,
(in millions)	2015			2014
Net sales
Fluid Handling	$	275.5		$	310.8
Payment & Merchandising Technologies	171.9			169.1
Aerospace & Electronics	161.6			169.0
Engineered Materials	69.7			67.9
Total	$	678.8		$	716.8
Operating profit (loss)
Fluid Handling ^a	$	34.3		$	44.5
Payment & Merchandising Technologies^b	21.1			7.4
Aerospace & Electronics ^c	30.1			32.6
Engineered Materials	14.3			10.8
Corporate ^d	(13.7		)	(13.9		)
Total	86.0			81.4
Interest income	0.5			0.4
Interest expense	(9.9		)	(9.8		)
Miscellaneous - net	(0.3		)	(0.2		)
Income before income taxes	$	76.3		$	71.8

^a Includes restructuring and related charges of $1.8 million for the three months ended March 31, 2015. Includes $3.2 million of restructuring charges for the three months ended March 31, 2014.

^bIncludes $0.2 million of restructuring charges and $1.6 million of acquisition integration related costs for the three months ended March 31, 2015. Includes $4.0 million of restructuring charges, $3.6 million of acquisition integration related costs and $4.8 million of acquisition related inventory step up and backlog amortization for the three months ended March 31, 2014.

^cIncludes $0.9 million of restructuring and related charges for the three months ended March 31, 2015. Includes $2.8 million of restructuring for the three months ended March 31, 2014.

^dIncludes $1.1 million of acquisition integration related costs for the three months ended March 31, 2014.



	As of
	March 31,		December 31,
(in millions)	2015		2014
Assets
Fluid Handling	$	905.3	$	963.2
Payment & Merchandising Technologies	1,202.5		1,210.1
Aerospace & Electronics	520.7		512.1
Engineered Materials	238.5		229.1
Corporate	520.4		536.3
Total	$	3,387.3	$	3,450.8



	As of
	March 31,		December 31,
(in millions)	2015		2014
Goodwill
Fluid Handling	$	218.7	$	227.3
Payment & Merchandising Technologies	581.3		589.9
Aerospace & Electronics	202.6		202.7
Engineered Materials	171.4		171.5
Total	$	1,174.0	$	1,191.3

Page 8

Note 3 - Earnings Per Share

The Company’s basic earnings per share calculations are based on the weighted average number of common shares outstanding during the period. Shares of restricted stock are included in the computation of both basic and diluted earnings per share. Potentially dilutive securities include outstanding stock options, restricted share units, deferred stock units and performance-based restricted share units. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury method. Diluted earnings per share gives effect to all potentially dilutive common shares outstanding during the year.



	Three Months Ended
	March 31,
(in millions, except per share data)	2015		2014
Net income attributable to common shareholders	$	51.1	$	48.7

Average basic shares outstanding	58.1		58.5
Effect of dilutive stock options	0.8		1.0
Average diluted shares outstanding	58.9		59.5

Earnings per basic share	$	0.88	$	0.83
Earnings per diluted share	$	0.87	$	0.82

The computation of diluted earnings per share excludes the effect of the potential exercise of stock options when the average market price of the common stock is lower than the exercise price of the related stock options during the period (0.8 million and 0.5 million average options were excluded for the first quarter of 2015 and 2014, respectively).

Note 4 - Changes in Equity and Comprehensive (Loss) Income

A summary of the changes in equity for the three months ended March 31, 2015 and 2014 is provided below:



	Three Months Ended March 31,
	2015									2014
(in millions)	Total Shareholders’ Equity			Noncontrolling Interests			Total Equity			Total Shareholders’ Equity			Noncontrolling Interests		Total Equity
Balance, beginning of period	$	1,059.8		$	10.8		$	1,070.6		$	1,204.3		$	10.4	$	1,214.7
Dividends	(19.1		)	—			(19.1		)	(17.6		)	—		(17.6		)
Reacquisition on open market	(25.0		)	—			(25.0		)	—			—		—
Exercise of stock options, net of shares reacquired	6.7			—			6.7			3.8			—		3.8
Stock compensation expense	5.8			—			5.8			5.6			—		5.6
Excess tax benefit from stock based compensation	0.9			—			0.9			5.1			—		5.1
Net income	51.1			0.3			51.3			48.7			0.2		48.9
Other comprehensive loss	(68.7		)	(0.2		)	(68.9		)	(1.0		)	—		(1.0		)
Comprehensive (loss) income	(17.7		)	0.1			(17.6		)	47.7			0.2		47.8
Balance, end of period	$	1,011.4		$	10.9		$	1,022.3		$	1,248.9		$	10.5	$	1,259.4

The table below provides the accumulated balances for each classification of accumulated other comprehensive (loss) income, as reflected on the Condensed Consolidated Balance Sheets.

Page 9



	(in millions)	Defined Benefit Pension and Other Postretirement Items*			Currency Translation Adjustment			Total

Balance as of December 31, 2014		$	(257.8	)	$	(40.9	)	$	(298.8	)
	Other comprehensive income (loss) before reclassifications	—			(70.7		)	(70.7		)
	Amounts reclassified from accumulated other comprehensive income	2.0			—			2.0
Net current-period other comprehensive income (loss)		2.0			(70.7		)	(68.7		)
Balance as of March 31, 2015		$	(255.8	)	$	(111.6	)	$	(367.5	)

* Net of tax benefit of $113.5 million and $114.4 million for March 31, 2015 and December 31, 2014, respectively.

The table below illustrates the amounts reclassified out of each component of accumulated other comprehensive income for the period ended March 31, 2015.



Details of Accumulated Other Comprehensive Income Components (in millions)	Amounts Reclassified from Accumulated Other Comprehensive Income			Affected Line Item in the Statement of Operations

Amortization of defined benefit pension items:
Prior-service costs	$	0.03		$.04 and ($.01) has been recorded within Cost of Sales and Selling, General & Administrative, respectively
Net loss (gain)	3.1			$4.2 and ($1.1) has been recorded within Cost of Sales and Selling, General & Administrative, respectively
Amortization of other postretirement items:
Prior-service costs	(0.1		)	Recorded within Selling, General & Administrative
Net loss (gain)	(0.1		)	Recorded within Selling, General & Administrative
	$	2.9		Total before tax
	1.0			Tax benefit
Total reclassifications for the period	$	2.0		Net of tax

Page 10

The table below illustrates the amounts reclassified out of each component of accumulated other comprehensive income for the period ended March 31, 2014.



Details of Accumulated Other Comprehensive Income Components (in millions)	Amounts Reclassified from Accumulated Other Comprehensive Income			Affected Line Item in the Statement of Operations

Amortization of defined benefit pension items:				Amortization of defined benefit pension items:
Prior-service costs	$	0.03		$.04 and ($.01) has been recorded within Cost of Sales and Selling, General & Administrative, respectively
Net loss (gain)	1.3			$1.7 and ($0.4) has been recorded within Cost of Sales and Selling, General & Administrative, respectively
Amortization of other postretirement items:
Prior-service costs	(0.1		)	Recorded within Selling, General & Administrative
Net loss (gain)	—			Recorded within Selling, General & Administrative
	$	1.2		Total before tax
	0.4			Tax benefit
Total reclassifications for the period	$	0.8		Net of tax

Note 5 - Acquisitions

On December 11, 2013, the Company completed the acquisition of MEI, a leading provider of payment solutions for unattended transaction systems, serving customers in the transportation, gaming, retail, financial services and vending markets. The purchase price was $804 million for all of the outstanding equity interests of MEI. MEI had sales of $399 million in 2012 and has been integrated into the Company's Crane Payment Innovations business within its Payment & Merchandising Technologies segment. The amount allocated to goodwill reflects the benefits the Company expects to realize from the acquisition, as the acquisition is expected to strengthen and broaden the Company’s product offering and will allow the Company to strengthen its global position in all sectors of the end market, as described above. Goodwill from this acquisition is not deductible for tax purposes.

To finance the cash consideration for the MEI acquisition, the Company issued $250 million of 2.75% Senior Notes due 2018 and $300 million of 4.45% Senior Notes due 2023. For the remainder of the cash consideration, the Company utilized cash and cash equivalents generated from operating activities.

Acquisition-Related Costs

Acquisition-related costs were expensed as incurred. For the quarter ended March 31, 2015, the Company recorded $1.6 million of acquisition integration related charges and $0.2 million of restructuring costs (see additional discussion in Note 14). For the quarter ended March 31, 2014, the Company recorded $4.7 million of acquisition integration related charges, $4.8 million of inventory step-up and backlog amortization and $4.0 million of restructuring costs (see additional discussion in Note 14).

Page 11

Note 6 - Goodwill and Intangible Assets

The Company’s business acquisitions have typically resulted in the recognition of goodwill and other intangible assets. The Company follows the provisions of ASC Topic 350, “Intangibles – Goodwill and Other” (“ASC 350”) as it relates to the accounting for goodwill in the Condensed Consolidated Financial Statements. These provisions require that the Company, on at least an annual basis, evaluate the fair value of the reporting units to which goodwill is assigned and attributed and compare that fair value to the carrying value of the reporting unit to determine if an impairment has occurred. The Company performs its annual impairment testing during the fourth quarter. Impairment testing takes place more often than annually if events or circumstances indicate a change in status that would indicate a potential impairment. The Company believes that there have been no events or circumstances which would more likely than not reduce the fair value for its reporting units below its carrying value. A reporting unit is an operating segment unless discrete financial information is prepared and reviewed by segment management for businesses one level below that operating segment (a “component”), in which case the component would be the reporting unit. In certain instances, the Company has aggregated components of an operating segment into a single reporting unit based on similar economic characteristics. At March 31, 2015, the Company had seven reporting units.

When performing its annual impairment assessment, the Company compares the fair value of each of its reporting units to its respective carrying value. Goodwill is considered to be potentially impaired when the net book value of the reporting unit exceeds its estimated fair value. Fair values are established primarily by discounting estimated future cash flows at an estimated cost of capital which varies for each reporting unit and which, as of the Company’s most recent annual impairment assessment, ranged between 9.5% and 13.5% (a weighted average of 10.7%), reflecting the respective inherent business risk of each of the reporting units tested. This methodology for valuing the Company’s reporting units (commonly referred to as the Income Method) has not changed since the adoption of the provisions under ASC 350. The determination of discounted cash flows is based on the businesses’ strategic plans and long-range planning forecasts, which change from year to year. The revenue growth rates included in the forecasts represent best estimates based on current and forecasted market conditions. Profit margin assumptions are projected by each reporting unit based on the current cost structure and anticipated net cost increases/reductions. There are inherent uncertainties related to these assumptions, including changes in market conditions, and management judgment is necessary in applying them to the analysis of goodwill impairment. In addition to the foregoing, for each reporting unit, market multiples are used to corroborate its discounted cash flow results where fair value is estimated based on earnings multiples determined by available public information of comparable businesses. While the Company believes it has made reasonable estimates and assumptions to calculate the fair value of its reporting units, it is possible a material change could occur. If actual results are not consistent with management’s estimates and assumptions, goodwill and other intangible assets may then be determined to be overstated and a charge would need to be taken against net earnings. Furthermore, in order to evaluate the sensitivity of the fair value calculations on the goodwill impairment test performed during the fourth quarter of 2014, the Company applied a hypothetical, reasonably possible 10% decrease to the fair values of each reporting unit. The effects of this hypothetical 10% decrease would still result in the fair value calculation exceeding the carrying value for each reporting unit.

Changes to goodwill are as follows:



(in millions)	Three Months Ended March 31, 2015			Year Ended December 31, 2014
Balance at beginning of period	$	1,191.3		$	1,249.3
Disposals	—			(0.8		)
Adjustments to purchase price allocations	—			(13.9		)
Currency translation and other	(17.3		)	(43.3		)
Balance at end of period	$	1,174.0		$	1,191.3

For the year ended December 31, 2014, the adjustments to purchase price allocations primarily included $6.1 million related to cash received by the Company as part of the final working capital adjustment of the December 2013 acquisition of MEI and $7.8 million of adjustments to preliminary asset valuations. The disposal represents goodwill associated with the pre-tax loss on sale of a small business divested in June 2014.

Page 12

Changes to intangible assets are as follows:



(in millions)	Three Months Ended March 31, 2015			Year Ended December 31, 2014
Balance at beginning of period, net of accumulated amortization	$	353.5		$	408.9
Amortization expense	(8.0		)	(37.9		)
Currency translation and other	(4.1		)	(17.6		)
Balance at end of period, net of accumulated amortization	$	341.3		$	353.5

As of March 31, 2015, the Company had $341.3 million of net intangible assets, of which $27.3 million were intangibles with indefinite useful lives, consisting of trade names. The Company amortizes the cost of other intangibles over their estimated useful lives unless such lives are deemed indefinite. Intangibles with indefinite useful lives are tested annually for impairment, or when events or changes in circumstances indicate the potential for impairment. If the carrying amount of an intangible asset with an indefinite useful life exceeds the fair value, the intangible asset is written down to its fair value. Fair value is calculated using discounted cash flows.

In addition to annual testing for impairment of indefinite-lived intangible assets, the Company reviews all of its long-lived assets, including intangible assets subject to amortization, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Examples of events or changes in circumstances could include, but are not limited to, a prolonged economic downturn, current period operating or cash flow losses combined with a history of losses or a forecast of continuing losses associated with the use of an asset or asset group, or a current expectation that an asset or asset group will be sold or disposed of before the end of its previously estimated useful life. Recoverability is based upon projections of anticipated future undiscounted cash flows associated with the use and eventual disposal of the long-lived asset (or asset group), as well as specific appraisal in certain instances. Reviews occur at the lowest level for which identifiable cash flows are largely independent of cash flows associated with other long-lived assets or asset groups and include estimated future revenues, gross profit margins, operating profit margins and capital expenditures which are based on the businesses’ strategic plans and long-range planning forecasts, which change from year to year. The revenue growth rates included in the forecasts represent our best estimates based on current and forecasted market conditions, and the profit margin assumptions are based on the current cost structure and anticipated net cost increases/reductions. There are inherent uncertainties related to these assumptions, including changes in market conditions, and management judgment is necessary in applying them to the analysis. If the future undiscounted cash flows are less than the carrying value, then the long-lived asset is considered impaired and a charge would be taken against net earnings based on the amount by which the carrying amount exceeds the estimated fair value. Judgments that the Company makes which impact these assessments relate to the expected useful lives of long-lived assets and its ability to realize any undiscounted cash flows in excess of the carrying amounts of such assets, and are affected primarily by changes in the expected use of the assets, changes in technology or development of alternative assets, changes in economic conditions, changes in operating performance and changes in expected future cash flows. Since judgment is involved in determining the fair value of long-lived assets, there is risk that the carrying value of our long-lived assets may require adjustment in future periods. Historical results to date have generally approximated expected cash flows for the identifiable cash flow generating level. The Company believes that there have been no events or circumstances which would more likely than not reduce the fair value of its indefinite-lived and amortizing intangible assets.

A summary of intangible assets follows:



	Weighted Average Amortization Period of Finite Lived Assets (in years)
		March 31, 2015						December 31, 2014
(in millions)		Gross Asset		Accumulated Amortization		Net		Gross Asset		Accumulated Amortization		Net
Intellectual property rights	16.5	$	88.6	$	50.2	$	38.4	$	91.3	$	50.4	$	40.9
Customer relationships and backlog	15.5	397.8		115.9		281.9		402.6		112.5		290.1
Drawings	37.9	11.1		10.1		1.1		11.1		10.1		1.1
Other	12.9	62.2		42.2		20.0		63.2		41.8		21.4
Total	15.8	$	559.7	$	218.4	$	341.3	$	568.2	$	214.8	$	353.5

Page 13

Amortization expense for these intangible assets is currently estimated to be approximately $23.7 million in total for the remainder of 2015, $30.5 million in 2016, $29.7 million in 2017, $26.9 million in 2018, $24.5 million in 2019 and $178.7 million in 2020 and thereafter.

Note 7 - Accrued Liabilities

Accrued liabilities consist of:



	March 31, 2015		December 31, 2014
(in millions)
Employee related expenses	$	68.6	$	81.4
Warranty	15.4		15.5
Other	144.4		128.8
Total	$	228.5	$	225.8

The Company accrues warranty liabilities when it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. Warranty provision is included in cost of sales in the Condensed Consolidated Statements of Operations. A summary of the warranty liabilities is as follows:



(in millions)	Three Months Ended March 31, 2015			Year Ended December 31, 2014
Balance at beginning of period	$	15.5		$	18.9
Expense	3.0			13.3
Changes due to acquisitions/divestitures	—			(0.1		)
Payments / deductions	(3.1		)	(16.4		)
Currency translation	(0.1		)	(0.2		)
Balance at end of period	$	15.4		$	15.5

Note 8 - Commitments and Contingencies

Asbestos Liability

Information Regarding Claims and Costs in the Tort System

As of March 31, 2015, the Company was a defendant in cases filed in numerous state and federal courts alleging injury or death as a result of exposure to asbestos. Activity related to asbestos claims during the periods indicated was as follows:



	Three Months Ended				Year Ended
	March 31,				December 31,
	2015		2014		2014
Beginning claims	47,507		51,490		51,490
New claims	633		680		2,743
Settlements	(208	)	(303	)	(992	)
Dismissals	(3,345	)	(968	)	(5,734	)
Ending claims	44,587		50,899		47,507

Of the 44,587 pending claims as of March 31, 2015, approximately 18,600 claims were pending in New York, approximately 7,300 claims were pending in Texas, approximately 5,100 claims were pending in Mississippi, and approximately 300 claims were pending in Ohio, all jurisdictions in which legislation or judicial orders restrict the types of claims that can proceed to trial on the merits.

Substantially all of the claims the Company resolves are either dismissed or concluded through settlements. To date, the Company has paid three judgments arising from adverse jury verdicts in asbestos matters. The first payment, in the amount of $2.54 million, was made on July 14, 2008, approximately two years after the adverse verdict in the Joseph Norris matter in California, after the Company had exhausted all post-trial and appellate remedies. The second payment, in the amount of $0.02

Page 14

million, was made in June 2009 after an adverse verdict in the Earl Haupt case in Los Angeles, California on April 21, 2009. The third payment, in the amount of $0.9 million, was made in June 2014, approximately two years after the adverse verdict in the William Paulus matter in California, after the Company had exhausted all post-trial and appellate remedies.

The Company has tried several cases resulting in defense verdicts by the jury or directed verdicts for the defense by the court. The Company further has pursued appeals of certain adverse jury verdicts that have resulted in reversals in favor of the defense.

On March 23, 2010, a Philadelphia, Pennsylvania, state court jury found the Company responsible for a 1/11th share of a $14.5 million verdict in the James Nelson claim, and for a 1/20th share of a $3.5 million verdict in the Larry Bell claim. On February 23, 2011, the court entered judgment on the verdicts in the amount of $0.2 million against the Company, only, in Bell, and in the amount of $4.0 million, jointly, against the Company and two other defendants in Nelson, with additional interest in the amount of $0.01 million being assessed against the Company, only, in Nelson. All defendants, including the Company, and the plaintiffs took timely appeals of certain aspects of those judgments. The Company resolved the Bell appeal by settlement, which is reflected in the settled claims for 2012. On September 5, 2013, a panel of the Pennsylvania Superior Court, in a 2-1 decision, vacated the Nelson verdict against all defendants, reversing and remanding for a new trial. Plaintiffs requested a rehearing in the Superior Court and by order dated November 18, 2013, the Superior Court vacated the panel opinion, and granted en banc reargument. On December 23, 2014, the Superior Court issued a second opinion reversing the jury verdict. Plaintiffs sought leave to appeal to the Pennsylvania Supreme Court, which defendants have opposed.

On August 17, 2011, a New York City state court jury found the Company responsible for a 99% share of a $32 million verdict on the Ronald Dummitt claim. The Company filed post-trial motions seeking to overturn the verdict, to grant a new trial, or to reduce the damages, which the Company argued were excessive under New York appellate case law governing awards for non-economic losses. The Court held oral argument on these motions on October 18, 2011 and issued a written decision on August 21, 2012 confirming the jury's liability findings but reducing the award of damages to $8 million. At plaintiffs' request, the Court entered a judgment in the amount of $4.9 million against the Company, taking into account settlement offsets and accrued interest under New York law. The Company appealed, and the judgment was affirmed in a 3-2 decision and order dated July 3, 2014. The Company has appealed to the New York Court of Appeals. The parties' briefing has concluded and oral argument will be heard in 2015.

On March 9, 2012, a Philadelphia, Pennsylvania, state court jury found the Company responsible for a 1/8th share of a $123,000 verdict in the Frank Paasch claim. The Company and plaintiffs filed post-trial motions. On May 31, 2012, on plaintiffs’ motion, the Court entered an order dismissing the claim against the Company, with prejudice, and without any payment.

On August 29, 2012, the Company received an adverse verdict in the William Paulus claim in Los Angeles, California. The jury found that the Company was responsible for ten percent (10%) of plaintiffs' non-economic damages of $6.5 million, plus a portion of plaintiffs' economic damages of $0.4 million. Based on California court rules regarding allocation of damages, judgment was entered in the amount of $0.8 million against the Company. The Company filed post-trial motions requesting judgment in the Company's favor notwithstanding the jury's verdict, which were denied. The Company appealed, and the judgment was affirmed by order dated February 21, 2014. The Company sought review of certain aspects of the ruling before the California Supreme Court, and review was denied. Having exhausted all post-trial and appellate remedies, the Company in June 2014 paid to plaintiffs the amount of $0.9 million, the judgment including interest, and this amount is included in the second quarter 2014 indemnity totals.

On October 23, 2012, the Company received an adverse verdict in the Gerald Suttner claim in Buffalo, New York. The jury found that the Company was responsible for four percent (4%) of plaintiffs' damages of $3 million. The Company filed post-trial motions requesting judgment in the Company's favor notwithstanding the jury's verdict, which were denied. The court entered a judgment of $0.1 million against the Company. The Company appealed, and the judgment was affirmed by order dated March 21, 2014. The Company sought reargument of this decision, which was denied. The Company sought review before the New York Court of Appeals, which was accepted in the fourth quarter of 2014. Oral argument will be heard in 2015.

On November 28, 2012, the Company received an adverse verdict in the James Hellam claim in Oakland, CA. The jury found that the Company was responsible for seven percent (7%) of plaintiffs' non-economic damages of $4.5 million, plus a portion of their economic damages of $0.9 million. Based on California court rules regarding allocation of damages, judgment was entered against the Company in the amount of $1.282 million. The Company filed post-trial motions requesting judgment in the Company's favor notwithstanding the jury's verdict and also requesting that settlement offsets be applied to reduce the judgment in accordance with California law. On January 31, 2013, the court entered an order disposing partially of that motion. On March 1, 2013, the Company filed an appeal regarding the portions of the motion that were denied. The court entered judgment against the Company in the amount of $1.1 million. The Company appealed. By opinion dated April 16, 2014, the Court of Appeal affirmed the finding of liability against the Company, and the California Supreme Court denied review of this

Page 15

ruling. The Court of Appeal reserved the arguments relating to recoverable damages to a subsequent appeal that remains pending.

On February 25, 2013, a Philadelphia, Pennsylvania, state court jury found the Company responsible for a 1/10th share of a $2.5 million verdict in the Thomas Amato claim and a 1/5th share of a $2.3 million verdict in the Frank Vinciguerra claim, which were consolidated for trial. The Company filed post-trial motions requesting judgments in the Company's favor notwithstanding the jury's verdicts or new trials, and also requesting that settlement offsets be applied to reduce the judgment in accordance with Pennsylvania law. These motions were denied. The Company has appealed, and on April 17, 2015, a panel of the Superior Court of Pennsylvania affirmed the trial court's ruling. The Company plans to file a motion for reconsideration and/or a request for review by the Pennsylvania Supreme Court.

On March 1, 2013, a New York City state court jury entered a $35 million verdict against the Company in the Ivo Peraica claim. The Company filed post-trial motions seeking to overturn the verdict, to grant a new trial, or to reduce the damages, which the Company argues were excessive under New York appellate case law governing awards for non-economic losses and further were subject to settlement offsets. After the trial court remitted the verdict to $18 million, but otherwise denied the Company’s post-trial motion, judgment also entered against the Company in the amount of $10.6 million (including interest). The Company has appealed. The Company has taken a separate appeal of the trial court’s denial of its summary judgment motion. The Court has consolidated the appeals, which were heard in the fourth quarter of 2014.

On July 31, 2013, a Buffalo, New York state court jury entered a $3.1 million verdict against the Company in the Lee Holdsworth claim. The Company filed post-trial motions seeking to overturn the verdict, to grant a new trial, or to reduce the damages, which the Company argues were excessive under New York appellate case law governing awards for non-economic losses and further were subject to settlement offsets. Post-trial motions were denied, and the court will set a hearing to assess the amount of damages. Plaintiffs requested judgment in the amount of $1.1 million, but have amended that request to seek judgment in the amount of $1.7 million. The Company plans to pursue an appeal.

On September 11, 2013, a Columbia, South Carolina state court jury in the Lloyd Garvin claim entered an $11 million verdict for compensatory damages against the Company and two other defendants jointly, and also awarded exemplary damages against the Company in the amount of $11 million. The jury also awarded exemplary damages against both other defendants. The Company filed post-trial motions seeking to overturn the verdict, which were denied, except that the Court remitted the compensatory damages award to $2.5 million and exemplary damages award to $3.5 million. Considering settlement offsets, the Court further reduced the total damages award to $3.5 million. The Company has settled the matter. The settlement is reflected in the first quarter 2015 indemnity amount.

On September 17, 2013, a Fort Lauderdale, Florida state court jury in the Richard DeLisle claim found the Company responsible for 16 percent of an $8 million verdict. The trial court denied all parties’ post-trial motions, and entered judgment against the Company in the amount of $1.3 million. The Company has appealed.

On June 16, 2014, a New York City state court jury entered a $15 million verdict against the Company in the Ivan Sweberg claim and a $10 million verdict against the Company in the Selwyn Hackshaw claim. The two claims were consolidated for trial. The Company filed post-trial motions seeking to overturn the verdicts, to grant new trials, or to reduce the damages, which were denied, except that the Court reduced the Sweberg award to $10 million, and reduced the Hackshaw award to $6 million. Judgments have been entered in the amount of $5.3 million in Sweberg and $3.1 million in Hackshaw. The Company has appealed.

Such judgment amounts are not included in the Company’s incurred costs until all available appeals are exhausted and the final payment amount is determined.

The gross settlement and defense costs incurred (before insurance recoveries and tax effects) for the Company for the three-month periods ended March 31, 2015 and 2014 totaled $18.3 million and $20.5 million, respectively. In contrast to the recognition of settlement and defense costs, which reflect the current level of activity in the tort system, cash payments and receipts generally lag the tort system activity by several months or more, and may show some fluctuation from quarter to quarter. Cash payments of settlement amounts are not made until all releases and other required documentation are received by the Company, and reimbursements of both settlement amounts and defense costs by insurers may be uneven due to insurer payment practices, transitions from one insurance layer to the next excess layer and the payment terms of certain reimbursement agreements. The Company’s total pre-tax payments for settlement and defense costs, net of funds received from insurers, for the three-month periods ended March 31, 2015 and 2014 totaled $10.7 million and $12.9 million, respectively. Detailed below are the comparable amounts for the periods indicated.

Page 16



	Three Months Ended						Year Ended
(in millions)	March 31,						December 31,
	2015			2014			2014
Settlement / indemnity costs incurred (1)	$	7.8		$	7.7		$	25.3
Defense costs incurred (1)	10.5			12.9			55.9
Total costs incurred	$	18.3		$	20.5		$	81.1

Settlement / indemnity payments	$	5.5		$	6.7		$	27.3
Defense payments	8.1			11.4			57.7
Insurance receipts	(2.9		)	(5.2		)	(23.8		)
Pre-tax cash payments	$	10.7		$	12.9		$	61.3


(1)	Before insurance recoveries and tax effects.

The amounts shown for settlement and defense costs incurred, and cash payments, are not necessarily indicative of future period amounts, which may be higher or lower than those reported.

Cumulatively through March 31, 2015, the Company has resolved (by settlement or dismissal) approximately 110,000 claims. The related settlement cost incurred by the Company and its insurance carriers is approximately $430 million, for an average settlement cost per resolved claim of approximately $3,900. The average settlement cost per claim resolved during the years ended December 31, 2014, 2013 and 2012 was $3,800, $3,300 and $6,300, respectively. Because claims are sometimes dismissed in large groups, the average cost per resolved claim, as well as the number of open claims, can fluctuate significantly from period to period. In addition to large group dismissals, the nature of the disease and corresponding settlement amounts for each claim resolved will also drive changes from period to period in the average settlement cost per claim. Accordingly, the average cost per resolved claim is not considered in the Company’s periodic review of its estimated asbestos liability. For a discussion regarding the four most significant factors affecting the liability estimate, see “Effects on the Condensed Consolidated Financial Statements”.

Effects on the Condensed Consolidated Financial Statements

The Company has retained the firm of Hamilton, Rabinovitz & Associates, Inc. (“HR&A”), a nationally recognized expert in the field, to assist management in estimating the Company’s asbestos liability in the tort system. HR&A reviews information provided by the Company concerning claims filed, settled and dismissed, amounts paid in settlements and relevant claim information such as the nature of the asbestos-related disease asserted by the claimant, the jurisdiction where filed and the time lag from filing to disposition of the claim. The methodology used by HR&A to project future asbestos costs is based largely on the Company’s experience during a base reference period of eleven quarterly periods (consisting of the two full preceding calendar years and three additional quarterly periods to the estimate date) for claims filed, settled and dismissed. The Company's experience is then compared to the results of widely used previously conducted epidemiological studies estimating the number of individuals likely to develop asbestos-related diseases. Those studies were undertaken in connection with national analyses of the population of workers believed to have been exposed to asbestos. Using that information, HR&A estimates the number of future claims that would be filed against the Company and estimates the aggregate settlement or indemnity costs that would be incurred to resolve both pending and future claims based upon the average settlement costs by disease during the reference period. This methodology has been accepted by numerous courts. After discussions with the Company, HR&A augments its liability estimate for the costs of defending asbestos claims in the tort system using a forecast from the Company which is based upon discussions with its defense counsel. Based on this information, HR&A compiles an estimate of the Company’s asbestos liability for pending and future claims, based on claim experience during the reference period and covering claims expected to be filed through the indicated forecast period. The most significant factors affecting the liability estimate are (1) the number of new mesothelioma claims filed against the Company, (2) the average settlement costs for mesothelioma claims, (3) the percentage of mesothelioma claims dismissed against the Company and (4) the aggregate defense costs incurred by the Company. These factors are interdependent, and no one factor predominates in determining the liability estimate. Although the methodology used by HR&A can be applied to show claims and costs for periods subsequent to the indicated period (up to and including the endpoint of the asbestos studies referred to above), management believes that the level of uncertainty regarding the various factors used in estimating future asbestos costs is too great to provide for reasonable estimation of the number of future claims, the nature of such claims or the cost to resolve them for years beyond the indicated estimate.

Page 17

In the Company’s view, the forecast period used to provide the best estimate for asbestos claims and related liabilities and costs is a judgment based upon a number of trend factors, including the number and type of claims being filed each year; the jurisdictions where such claims are filed, and the effect of any legislation or judicial orders in such jurisdictions restricting the types of claims that can proceed to trial on the merits; and the likelihood of any comprehensive asbestos legislation at the federal level. In addition, the dynamics of asbestos litigation in the tort system have been significantly affected over the past five to ten years by the substantial number of companies that have filed for bankruptcy protection, thereby staying any asbestos claims against them until the conclusion of such proceedings, and the establishment of a number of post-bankruptcy trusts for asbestos claimants, which are estimated to provide $36 billion for payments to current and future claimants. These trend factors have both positive and negative effects on the dynamics of asbestos litigation in the tort system and the related best estimate of the Company’s asbestos liability, and these effects do not move in a linear fashion but rather change over multi-year periods. Accordingly, the Company’s management continues to monitor these trend factors over time and periodically assesses whether an alternative forecast period is appropriate.

Each quarter, HR&A compiles an update based upon the Company’s experience in claims filed, settled and dismissed during the updated reference period (consisting of the preceding eleven quarterly periods) as well as average settlement costs by disease category (mesothelioma, lung cancer, other cancer and non-malignant conditions including asbestosis) during that period. In addition to this claims experience, the Company also considers additional quantitative and qualitative factors such as the nature of the aging of pending claims, significant appellate rulings and legislative developments, and their respective effects on expected future settlement values. As part of this process, the Company also takes into account trends in the tort system such as those enumerated above. Management considers all these factors in conjunction with the liability estimate of HR&A and determines whether a change in the estimate is warranted.

Liability Estimate. With the assistance of HR&A, effective as of December 31, 2011, the Company updated and extended its estimate of the asbestos liability, including the costs of settlement or indemnity payments and defense costs relating to currently pending claims and future claims projected to be filed against the Company through 2021. The Company’s previous estimate was for asbestos claims filed or projected to be filed through 2017. As a result of this updated estimate, the Company recorded an additional liability of $285 million as of December 31, 2011. The Company’s decision to take this action at such date was based on several factors which contribute to the Company’s ability to reasonably estimate this liability for the additional period noted. First, the number of mesothelioma claims (which although constituting approximately 8% of the Company’s total pending asbestos claims, have accounted for approximately 90% of the Company’s aggregate settlement and defense costs) being filed against the Company and associated settlement costs have recently stabilized. In the Company’s opinion, the outlook for mesothelioma claims expected to be filed and resolved in the forecast period is reasonably stable. Second, there have been favorable developments in the trend of case law which has been a contributing factor in stabilizing the asbestos claims activity and related settlement costs. Third, there have been significant actions taken by certain state legislatures and courts over the past several years that have reduced the number and types of claims that can proceed to trial, which has been a significant factor in stabilizing the asbestos claims activity. Fourth, the Company has now entered into coverage-in-place agreements with almost all of its excess insurers, which enables the Company to project a more stable relationship between settlement and defense costs paid by the Company and reimbursements from its insurers. Taking all of these factors into account, the Company believes that it can reasonably estimate the asbestos liability for pending claims and future claims to be filed through 2021. While it is probable that the Company will incur additional charges for asbestos liabilities and defense costs in excess of the amounts currently provided, the Company does not believe that any such amount can be reasonably estimated beyond 2021. Accordingly, no accrual has been recorded for any costs which may be incurred for claims which may be made subsequent to 2021.

Management has made its best estimate of the costs through 2021 based on the analysis by HR&A completed in January 2012. Through March 31, 2015, the Company’s actual experience during the updated reference period for mesothelioma claims filed and dismissed generally approximated the assumptions in the Company’s liability estimate. In addition to this claims experience, the Company considered additional quantitative and qualitative factors such as the nature of the aging of pending claims, significant appellate rulings and legislative developments, and their respective effects on expected future settlement values. Based on this evaluation, the Company determined that no change in the estimate was warranted for the period ended March 31, 2015. Nevertheless, if certain factors show a pattern of sustained increase or decrease, the liability could change materially; however, all the assumptions used in estimating the asbestos liability are interdependent and no single factor predominates in determining the liability estimate. Because of the uncertainty with regard to and the interdependency of such factors used in the calculation of its asbestos liability, and since no one factor predominates, the Company believes that a range of potential liability estimates beyond the indicated forecast period cannot be reasonably estimated.

A liability of $894 million was recorded as of December 31, 2011 to cover the estimated cost of asbestos claims now pending or subsequently asserted through 2021, of which approximately 80% is attributable to settlement and defense costs for future claims projected to be filed through 2021. The liability is reduced when cash payments are made in respect of settled claims

Page 18

and defense costs. The liability was $600 million as of March 31, 2015. It is not possible to forecast when cash payments related to the asbestos liability will be fully expended; however, it is expected such cash payments will continue for a number of years past 2021, due to the significant proportion of future claims included in the estimated asbestos liability and the lag time between the date a claim is filed and when it is resolved. None of these estimated costs have been discounted to present value due to the inability to reliably forecast the timing of payments. The current portion of the total estimated liability at March 31, 2015 was $79 million and represents the Company’s best estimate of total asbestos costs expected to be paid during the twelve-month period. Such amount is based upon the HR&A model together with the Company’s prior year payment experience for both settlement and defense costs.

Insurance Coverage and Receivables. Prior to 2005, a significant portion of the Company’s settlement and defense costs were paid by its primary insurers. With the exhaustion of that primary coverage, the Company began negotiations with its excess insurers to reimburse the Company for a portion of its settlement and/or defense costs as incurred. To date, the Company has entered into agreements providing for such reimbursements, known as “coverage-in-place”, with eleven of its excess insurer groups. Under such coverage-in-place agreements, an insurer’s policies remain in force and the insurer undertakes to provide coverage for the Company’s present and future asbestos claims on specified terms and conditions that address, among other things, the share of asbestos claims costs to be paid by the insurer, payment terms, claims handling procedures and the expiration of the insurer’s obligations. Similarly, under a variant of coverage-in-place, the Company has entered into an agreement with a group of insurers confirming the aggregate amount of available coverage under the subject policies and setting forth a schedule for future reimbursement payments to the Company based on aggregate indemnity and defense payments made. In addition, with ten of its excess insurer groups, the Company entered into policy buyout agreements, settling all asbestos and other coverage obligations for an agreed sum, totaling $82.5 million in aggregate. Reimbursements from insurers for past and ongoing settlement and defense costs allocable to their policies have been made in accordance with these coverage-in-place and other agreements. All of these agreements include provisions for mutual releases, indemnification of the insurer and, for coverage-in-place, claims handling procedures. With the agreements referenced above, the Company has concluded settlements with all but one of its solvent excess insurers whose policies are expected to respond to the aggregate costs included in the updated liability estimate. That insurer, which issued a single applicable policy, has been paying the shares of defense and indemnity costs the Company has allocated to it, subject to a reservation of rights. There are no pending legal proceedings between the Company and any insurer contesting the Company’s asbestos claims under its insurance policies.

In conjunction with developing the aggregate liability estimate referenced above, the Company also developed an estimate of probable insurance recoveries for its asbestos liabilities. In developing this estimate, the Company considered its coverage-in-place and other settlement agreements described above, as well as a number of additional factors. These additional factors include the financial viability of the insurance companies, the method by which losses will be allocated to the various insurance policies and the years covered by those policies, how settlement and defense costs will be covered by the insurance policies and interpretation of the effect on coverage of various policy terms and limits and their interrelationships. In addition, the timing and amount of reimbursements will vary because the Company’s insurance coverage for asbestos claims involves multiple insurers, with different policy terms and certain gaps in coverage. In addition to consulting with legal counsel on these insurance matters, the Company retained insurance consultants to assist management in the estimation of probable insurance recoveries based upon the aggregate liability estimate described above and assuming the continued viability of all solvent insurance carriers. Based upon the analysis of policy terms and other factors noted above by the Company’s legal counsel, and incorporating risk mitigation judgments by the Company where policy terms or other factors were not certain, the Company’s insurance consultants compiled a model indicating how the Company’s historical insurance policies would respond to varying levels of asbestos settlement and defense costs and the allocation of such costs between such insurers and the Company. Using the estimated liability as of December 31, 2011 (for claims filed or expected to be filed through 2021), the insurance consultant’s model forecasted that approximately 25% of the liability would be reimbursed by the Company’s insurers. While there are overall limits on the aggregate amount of insurance available to the Company with respect to asbestos claims, those overall limits were not reached by the total estimated liability currently recorded by the Company, and such overall limits did not influence the Company in its determination of the asset amount to record. The proportion of the asbestos liability that is allocated to certain insurance coverage years, however, exceeds the limits of available insurance in those years. The Company allocates to itself the amount of the asbestos liability (for claims filed or expected to be filed through 2021) that is in excess of available insurance coverage allocated to such years. An asset of $225 million was recorded as of December 31, 2011 representing the probable insurance reimbursement for such claims expected through 2021. The asset is reduced as reimbursements and other payments from insurers are received. The asset was $144 million as of March 31, 2015.

The Company reviews the aforementioned estimated reimbursement rate with its insurance consultants on a periodic basis in order to confirm its overall consistency with the Company’s established reserves. The reviews encompass consideration of the performance of the insurers under coverage-in-place agreements and the effect of any additional lump-sum payments under policy buyout agreements. Since December 2011, there have been no developments that have caused the Company to change

Page 19

the estimated 25% rate, although actual insurance reimbursements vary from period to period, and will decline over time, for the reasons cited above.

Uncertainties. Estimation of the Company’s ultimate exposure for asbestos-related claims is subject to significant uncertainties, as there are multiple variables that can affect the timing, severity and quantity of claims and the manner of their resolution. The Company cautions that its estimated liability is based on assumptions with respect to future claims, settlement and defense costs based on past experience that may not prove reliable as predictors. A significant upward or downward trend in the number of claims filed, depending on the nature of the alleged injury, the jurisdiction where filed and the quality of the product identification, or a significant upward or downward trend in the costs of defending claims, could change the estimated liability, as would substantial adverse verdicts at trial that withstand appeal. A legislative solution, structured settlement transaction, or significant change in relevant case law could also change the estimated liability.

The same factors that affect developing estimates of probable settlement and defense costs for asbestos-related liabilities also affect estimates of the probable insurance reimbursements, as do a number of additional factors. These additional factors include the financial viability of the insurance companies, the method by which losses will be allocated to the various insurance policies and the years covered by those policies, how settlement and defense costs will be covered by the insurance policies and interpretation of the effect on coverage of various policy terms and limits and their interrelationships. In addition, due to the uncertainties inherent in litigation matters, no assurances can be given regarding the outcome of any litigation, if necessary, to enforce the Company’s rights under its insurance policies or settlement agreements.

Many uncertainties exist surrounding asbestos litigation, and the Company will continue to evaluate its estimated asbestos-related liability and corresponding estimated insurance reimbursement as well as the underlying assumptions and process used to derive these amounts. These uncertainties may result in the Company incurring future charges or increases to income to adjust the carrying value of recorded liabilities and assets, particularly if the number of claims and settlement and defense costs change significantly, or if there are significant developments in the trend of case law or court procedures, or if legislation or another alternative solution is implemented; however, the Company is currently unable to estimate such future changes and, accordingly, while it is probable that the Company will incur additional charges for asbestos liabilities and defense costs in excess of the amounts currently provided, the Company does not believe that any such amount can be reasonably determined beyond 2021. Although the resolution of these claims may take many years, the effect on the results of operations, financial position and cash flow in any given period from a revision to these estimates could be material.

Other Contingencies

Environmental Matters

For environmental matters, the Company records a liability for estimated remediation costs when it is probable that the Company will be responsible for such costs and they can be reasonably estimated. Generally, third party specialists assist in the estimation of remediation costs. The environmental remediation liability as of March 31, 2015 is substantially related to the former manufacturing sites in Goodyear, Arizona (the “Goodyear Site”) and Roseland, NJ ("Roseland Site") each discussed below.

The Goodyear Site was operated by UniDynamics/Phoenix, Inc. (“UPI”), which became an indirect subsidiary of the Company in 1985 when the Company acquired UPI’s parent company, UniDynamics Corporation. UPI manufactured explosive and pyrotechnic compounds, including components for critical military programs, for the U.S. government at the Goodyear Site from 1962 to 1993, under contracts with the Department of Defense and other government agencies and certain of their prime contractors. No manufacturing operations have been conducted at the Goodyear Site since 1994. The Goodyear Site was placed on the National Priorities List in 1983, and is now part of the Phoenix-Goodyear Airport North Superfund Site. In 1990, the U.S. Environmental Protection Agency (“EPA”) issued administrative orders requiring UPI to design and carry out certain remedial actions, which UPI has done. Groundwater extraction and treatment systems have been in operation at the Goodyear Site since 1994. A soil vapor extraction system was in operation from 1994 to 1998, was restarted in 2004, and is currently in operation. The Company recorded a liability in 2004 for estimated costs to remediate the Goodyear Site. On July 26, 2006, the Company entered into a consent decree with the EPA with respect to the Goodyear Site providing for, among other things, a work plan for further investigation and remediation activities (inclusive of a supplemental remediation investigation and feasibility study). During the fourth quarter of 2007, the Company and its technical advisors determined that changing groundwater flow rates and contaminant plume direction at the Goodyear Site required additional extraction systems as well as modifications and upgrades of the existing systems. In consultation with its technical advisors, the Company prepared a forecast of the expenditures required for these new and upgraded systems as well as the costs of operation over the forecast period through 2014. Taking these additional costs into consideration, the Company estimated its liability for the costs of such activities through 2014 to be $41.5 million as of December 31, 2007. During the fourth quarter of 2008, based on further consultation with the Company’s advisors and the EPA and in response to groundwater monitoring results that reflected a

Page 20

continuing migration in contaminant plume direction during the year, the Company revised its forecast of remedial activities to increase the level of extraction systems and the number of monitoring wells in and around the Goodyear Site, among other things. As of December 31, 2008, the revised liability estimate was $65.2 million which resulted in an additional charge of $24.3 million during the fourth quarter of 2008. During the fourth quarter of 2011, additional remediation activities were determined to be required, in consultation with the Company’s advisors, to further address the migration of the contaminant plume. As a result, the Company recorded a charge of $30.3 million during the fourth quarter of 2011, extending the accrued costs through 2016. During the third quarter of 2014, the EPA issued a Record of Decision amendment requiring, among other things, additional source area remediation resulting in the Company recording a charge of $49.0 million, extending the accrued costs through 2022. The total estimated gross liability was $75.6 million as of March 31, 2015, and as described below, a portion is reimbursable by the U.S. Government. The current portion of the total estimated liability was approximately $15.5 million and represents the Company’s best estimate, in consultation with its technical advisors, of total remediation costs expected to be paid during the twelve-month period.

Estimates of the Company’s environmental liabilities at the Goodyear Site are based on currently available facts, present laws and regulations and current technology available for remediation, and are recorded on an undiscounted basis. These estimates consider the Company’s prior experience in the Goodyear Site investigation and remediation, as well as available data from, and in consultation with, the Company’s environmental specialists. Estimates at the Goodyear Site are subject to significant uncertainties caused primarily by the dynamic nature of the Goodyear Site conditions, the range of remediation alternatives available, together with the corresponding estimates of cleanup methodology and costs, as well as ongoing, required regulatory approvals, primarily from the EPA. Accordingly, it is likely that upon completing the supplemental remediation investigation and the feasibility study and reaching a final work plan, which is now expected to be completed in or before 2019, an adjustment to the Company’s liability estimate may be necessary to account for the agreed upon additional work as further information and circumstances regarding the Goodyear Site characterization develop. While actual remediation cost therefore may be more than amounts accrued, the Company believes it has established adequate reserves for all probable and reasonably estimable costs.

It is not possible at this point to reasonably estimate the amount of any obligation in excess of the Company’s current accruals through the 2022 forecast period because of the aforementioned uncertainties, in particular, the continued significant changes in the Goodyear Site conditions and additional expectations of remediation activities experienced in recent years.

On July 31, 2006, the Company entered into a consent decree with the U.S. Department of Justice on behalf of the Department of Defense and the Department of Energy pursuant to which, among other things, the U.S. Government reimburses the Company for 21% of qualifying costs of investigation and remediation activities at the Goodyear Site. As of March 31, 2015, the Company has recorded a receivable of $17.1 million for the expected reimbursements from the U.S. Government in respect of the aggregate liability as at that date. The receivable is reduced as reimbursements and other payments from the U.S. Government are received.

Roseland Site

The Roseland Site was operated by Resistoflex Corporation (“Resistoflex”), which became an indirect subsidiary of the Company in 1985 when the Company acquired Resistoflex’s parent company, UniDynamics Corporation. Resistoflex manufactured specialty lined pipe and fittings at the site from the 1950s until it was closed in the mid-1980s. In 2009, at the request of the New Jersey Department of Environmental Protection (“NJDEP”), the Company performed certain tests of the indoor air quality of approximately 40 homes in a residential area surrounding the Roseland Site to determine if any contaminants (volatile organic compound vapors from groundwater) from the Roseland Site were present in those homes. The test results showed that three homes had volatile organic compound vapors above NJ DEP's recommended concentration levels, and the Company installed vapor mitigation equipment in those homes. On April 15, 2011, those three homeowners, and the tenants in one of those homes, filed separate suits against the Company seeking unspecified compensatory and punitive damages for their lost property value and nuisance. In addition, a homeowner in the testing area, whose home tested negative for the presence of contaminants, filed a class action suit against the Company on behalf of himself and 138 other homeowners in the surrounding area, claiming damages in the nature of loss of value on their homes due to their proximity to the Roseland Site. The plaintiffs in these cases amended their complaints to assert claims under New Jersey's Environmental Rights Act for the Company's alleged failure to properly report its waste discharge practices in the late 1960s and early 1970s, and for natural resource damages. In late December 2013, the plaintiffs moved to have a class of 139 homeowners certified, and the motion was granted in early February 2014. At the same time the Court also entered partial summary judgment on liability for the three homes where the Company had installed vapor mitigation equipment. The Company reached an agreement to settle all current claims with the class and individual plaintiffs for a one-time payment of $6.5 million. This agreement was approved by the

Page 21

Court on July 23, 2014 and the Company completed all obligations required of it to complete the settlement on October 10, 2014.

The Company undertook an extensive soil remediation effort at the Roseland Site following its closure, and had been monitoring the Site’s condition in the years that followed. In response to changes in remediation standards, the Company has conducted further site characterization and delineation studies. In the three months ended September 30, 2014, the Company, in consultation with its advisors, substantially completed its assessment of soil and groundwater contaminants at the Roseland Site, and developed an enhanced remediation plan for the site, which includes further soil removal, groundwater treatment, and soil vapor extraction, resulting in a charge of $6.8 million for remediation activities which are expected to be completed by 2017. Estimates of the Company’s environmental liabilities at the Roseland Site are based on currently available facts, present laws and regulations and current technology available for remediation, and are recorded on an undiscounted basis. While actual remediation cost may be more or less than amounts accrued, the Company believes it has established adequate reserves for all probable and reasonably estimable costs.

Other Environmental Matters

The Company has been identified as a potentially responsible party (“PRP”) with respect to environmental contamination at the Crab Orchard National Wildlife Refuge Superfund Site (the “Crab Orchard Site”). The Crab Orchard Site is located near Marion, Illinois, and consists of approximately 55,000 acres. Beginning in 1941, the United States used the Crab Orchard Site for the production of ordnance and other related products for use in World War II. In 1947, the Crab Orchard Site was transferred to the United States Fish and Wildlife Service (“FWS”), and about half of the Crab Orchard Site was leased to a variety of industrial tenants whose activities (which continue to this day) included manufacturing ordnance and explosives. A predecessor to the Company formerly leased portions of the Crab Orchard Site, and conducted manufacturing operations at the Crab Orchard Site from 1952 until 1964. General Dynamics Ordnance and Tactical Systems, Inc. (“GD-OTS”) is in the process of conducting a remedial investigation and feasibility study for the Additional and Uncharacterized Sites Operable Unit (“AUS-OU”) at the Crab Orchard Site, pursuant to an Administrative Order on Consent between GD-OTS and the FWS, the EPA and the Illinois Environmental Protection Agency. The Company is not a party to that agreement, and has not been asked by any agency of the United States Government or the State of Illinois to participate in any investigative or remedial activity relative to the Crab Orchard Site. The Company has been informed that GD-OTS completed a Phase I remedial investigation in 2008, and a Phase II remedial investigation in 2010. Additionally, FWS completed initial human health and baseline ecological risk assessments in 2010, and its revised human health risk assessment and baseline ecological risk assessment were completed in June 2014. In January 2015, GD-OTS submitted a final remedial investigation report, which FWS approved on February 13, 2015. GD-OTS further reports that additional plant and invertebrate tissue sampling is projected to take place in Spring 2015. Work on interim deliverables for the feasibility study is reportedly underway, with submission of the draft remedial action options memorandum scheduled for May 2015, submission of the Preliminary Screening of Alternatives memorandum scheduled for August 2015, and submission of the Comparative Analysis of Alternatives memorandum scheduled for November 2015. Submission of a draft feasibility study report is projected for spring 2016. It is unclear when a final Record of Decision may be issued.

GD-OTS has asked the Company to participate in a voluntary cost allocation/mediation exercise with respect to response costs it has incurred or will incur with respect to the AUS-OU. The Company, along with a number of other PRPs that were contacted, initially declined, citing the absence of certain necessary parties as well as an underdeveloped environmental record. More recently, in light of the ongoing investigative activities, and the apparent willingness of the U.S. government to participate in a mediation proceeding, a number of PRPs (including GD-OTS, the U.S. government, and the Company) have indicated their intention to participate in a non-binding mediation process, and have agreed upon the terms of a mediation process agreement. The Company and other PRPs executed this mediation agreement on March 16, 2015. The U.S. government has yet to execute the mediation agreement, however, pending resolution of a dispute between the U.S. Army and FWS over the contents of the remedial investigation report. The Company at present cannot predict when any determination of the allocable share of the various PRPs, including the U.S. Government, is likely to be completed. Although a loss is probable, it is not possible at this time to reasonably estimate the amount of any obligation for remediation of the Crab Orchard Site because the extent of the environmental impact, allocation among PRPs, remediation alternatives, and concurrence of regulatory authorities have not yet advanced to the stage where a reasonable estimate can be made. The Company has notified its insurers of this potential liability and will seek coverage under its insurance policies.

On a related matter, the United States brought suit against GD-OTS and Schlumberger Technology Corporation (“Schlumberger”), seeking to recover response costs that the United States has allegedly incurred in connection with alleged environmental contamination at a portion of the Crab Orchard Site known as “Site 36,” which is within the Site's Miscellaneous Areas Operable Unit. This area, reported to be the wastewater treatment plant formerly serving the Crab Orchard Site, is not a part of the AUS-OU, as discussed above. On June 1, 2012, GD-OTS and Schlumberger filed a third-party complaint against the

Page 22

Company and seven other third-party defendants, seeking to shift a portion of any costs that GD-OTS and Schlumberger are held liable to pay to other entities formerly conducting activities at Site 36. GD-OTS and Schlumberger also counterclaimed against the United States, seeking to compel the United States to bear a share of the response costs the United States allegedly has incurred. The United States, GD-OTS, Schlumberger, the Company, and all remaining third-party defendants resolved their claims against each other and finalized the terms of a consent decree, which was entered by the Court on April 1, 2014. Pursuant to the parties’ agreement, the Company paid $166,667 to resolve all past and future claims for response costs relating to Site 36. The Company notified its insurers of this liability and has obtained an agreement for coverage for the settlement amount referenced above.

Other Proceedings

A number of other lawsuits, claims and proceedings have been or may be asserted against the Company relating to the conduct of its business, including those pertaining to product liability, patent infringement, commercial, employment, employee benefits, environmental and stockholder matters. While the outcome of litigation cannot be predicted with certainty, and some of these other lawsuits, claims or proceedings may be determined adversely to the Company, the Company does not believe that the disposition of any such other pending matters is likely to have a material impact on its financial condition or liquidity, although the resolution in any reporting period of one or more of these matters could have a significant impact on the Company's results of operations and cash flows for that period.

Other Commitments

The Company entered into a five year operating lease for an airplane in the first quarter of 2014 which included a maximum residual value guarantee of $7.8 million by the Company if the fair value of the airplane is less than $9.5 million at the end of the lease term. In 2014, the Company made a $9.5 million residual value guarantee payment in connection with the previous airplane lease which ended January 30, 2014 . This payment was reported within "Other" in “Total used for operating activities” on the Condensed Consolidated Statements of Cash Flows.

Page 23

Note 9 - Pension and Other Postretirement Benefit Plans

The components of net periodic benefit are as follows:



	Three Months Ended March 31,
	2015			2014			2015			2014
(in millions)	Pension Benefits						Other Postretirement Benefits
Service cost	$	1.4		$	1.3		$	—		$	—
Interest cost	9.6			10.2			0.1			0.1
Expected return on plan assets	(15.6		)	(15.7		)	—			—
Amortization of prior service cost	—			—			(0.1		)	(0.1		)
Amortization of net loss (gain)	3.1			1.3			(0.1		)	—
Net periodic benefit	$	(1.5	)	$	(2.9	)	$	(0.1	)	$	—

The Company expects, based on current actuarial calculations, to contribute approximately $17.0 million to its defined benefit plans and $1.0 million to its other postretirement benefit plans in 2015, of which $2.9 million and $0.1 million have been contributed during the first three months of 2015, respectively. The Company contributed $24.5 million to its defined benefit plans and $1.0 million to its other postretirement benefit plans in 2014. Cash contributions for subsequent years will depend on a number of factors, including the impact of the Pension Protection Act signed into law in 2006, changes in minimum funding requirements, long-term interest rates, the investment performance of plan assets and changes in employee census data affecting the Company’s projected benefit obligations.

Note 10 - Income Taxes

Effective Tax Rates

The Company's effective tax rates are as follows:



	2015	2014
Three months ended March 31,	32.7%	31.9%

The Company’s effective tax rate for the three months ended March 31, 2015 is higher than the prior year’s comparable period primarily due to the unfavorable impacts of recently-enacted Japanese tax reform on certain tax carryforwards and a lower U.S. federal tax benefit on domestic manufacturing activities, partially offset by the favorable impacts of income earned in jurisdictions with lower statutory tax rates and a lower amount of statutorily non-deductible expenses.

The Company's effective tax rate for the three months ended March 31, 2015 is lower than the statutory U.S. federal tax rate of 35% primarily due to the favorable impacts of income earned in jurisdictions with tax rates lower than the U.S. statutory rate and the U.S. federal tax benefit for domestic manufacturing activities, partially offset by the unfavorable impacts of U.S. state taxes and certain expenses that are statutorily non-deductible for income tax purposes.

Unrecognized Tax Benefits

During the three months ended March 31, 2015, the Company's gross unrecognized tax benefits, excluding interest and penalties, decreased by $0.1 million primarily as a result of tax positions taken in both the current and prior periods. During the three months ended March 31, 2015, the total amount of unrecognized tax benefits that, if recognized, would affect the Company's effective tax rate decreased by less than $0.1 million.

The Company recognizes interest and penalties related to unrecognized tax benefits as a component of its income tax expense. During the three months ended March 31, 2015, the Company recognized $0.3 million of interest and penalty expense related to unrecognized tax benefits in its condensed consolidated statement of operations. At March 31, 2015 and December 31, 2014, the total amount of accrued interest and penalty expense related to unrecognized tax benefits recorded in the Company’s condensed consolidated balance sheets was $5.0 million and $4.7 million, respectively.

During the next twelve months, it is reasonably possible that the Company's unrecognized tax benefits may decrease by $4.6 million due to settlements of income tax examinations, the expiration of statutes of limitations or other resolution of

Page 24

uncertainties. However, if the ultimate resolution of income tax examinations results in amounts that differ from this estimate, the Company will record additional income tax expense or benefit in the period in which such matters are effectively settled.

Income Tax Examinations

The Company's income tax returns are subject to examination by the U.S. federal, U.S. state and local, and non-U.S. tax authorities.

The Company’s federal income tax returns for the years 2010 through 2012 are currently under examination by the U.S. Internal Revenue Service, and its federal income tax return for 2013 remains subject to examination. In addition, acquired subsidiaries’ federal income tax returns (2011 through 2013) and federal tax carry forwards (2006 through 2013) remain subject to examination.

With few exceptions, the Company is no longer subject to U.S. state and local or non-U.S. income tax examinations for years before 2009. Currently, the Company and its subsidiaries are under examination in various jurisdictions, including Germany (2006 through 2012).

Note 11 - Long-Term Debt and Short-Term Borrowings

The following table summarizes the Company’s debt as of March 31, 2015 and December 31, 2014:



(in millions)	March 31, 2015		December 31, 2014
Long-term debt consists of:
2.75% notes due 2018	$	250.0	$	250.0
4.45% notes due 2023	300.0		300.0
6.55% notes due 2036	199.3		199.3
Total long-term debt	$	749.2	$	749.2

Short-term borrowings consists of:
Revolving credit facility	$	—	$	100.0
Commercial paper	126.7		—
Other	0.8		0.8
Total short-term borrowings	$	127.5	$	100.8

On March 2, 2015, the Company entered into a commercial paper program (the “CP Program”) pursuant to which it may issue short-term, unsecured commercial paper notes (the “Notes”) pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. Amounts available under the CP Program may be borrowed, repaid and re-borrowed from time to time, with the aggregate principal amount of the Notes outstanding under the CP Program at any time not to exceed $500 million. The Notes will have maturities of up to 397 days from date of issue. The Notes will rank at least pari passu with all of our other unsecured and unsubordinated indebtedness. At March 31, 2015, Notes with a principal amount of $127 million were outstanding. The net proceeds of the issuances of the Notes were used to repay amounts under our revolving credit facility and for general corporate purposes.

Page 25

Note 12 - Derivative Instruments and Hedging Activities

The Company is exposed to certain risks related to its ongoing business operations, including market risks related to fluctuation in currency exchange. The Company uses foreign exchange contracts to manage the risk of certain cross-currency business relationships to minimize the impact of currency exchange fluctuations on the Company’s earnings and cash flows. The Company does not hold or issue derivative financial instruments for trading or speculative purposes. As of March 31, 2015, the foreign exchange contracts designated as hedging instruments did not have a material impact on the Company’s statement of operations, balance sheet or cash flows. Foreign exchange contracts not designated as hedging instruments, which primarily pertain to foreign exchange fluctuation risk of intercompany positions, had a notional value of $198 million and $216 million as of March 31, 2015 and December 31, 2014, respectively. The settlement of derivative contracts for the three months ended March 31, 2015 and 2014 resulted in a net cash outflow of $12.0 million and $2.7 million, respectively, and is reported within other in “Total used for operating activities” on the Condensed Consolidated Statements of Cash Flows. As of March 31, 2015 and December 31, 2014, the Company's receivable position for the foreign exchange contracts was $0.1 million and $31 thousand, respectively. As of March 31, 2015 and December 31, 2014, the Company's payable position for the foreign exchange contracts was $2.9 million and $2.5 million, respectively.

Note 13 - Fair Value Measurements

Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurements are to be considered from the perspective of a market participant that holds the asset or owes the liability. The standards also establish a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The standards describe three levels of inputs that may be used to measure fair value:

Level 1: Quoted prices in active markets for identical or similar assets and liabilities.

Level 2: Quoted prices for identical or similar assets and liabilities in markets that are not active or observable inputs other than quoted prices in active markets for identical or similar assets and liabilities. Level 2 assets and liabilities include over-the-counter derivatives, principally forward foreign exchange contracts, whose value is determined using pricing models with inputs that are generally based on published foreign exchange rates and exchange traded prices, adjusted for other specific inputs that are primarily observable in the market or can be derived principally from or corroborated by observable market data.

Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The following table summarizes assets and liabilities measured at fair value on a recurring basis at the dates indicated:



	March 31, 2015								December 31, 2014
	Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs				Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
(in millions)	Level 1		Level 2		Level 3		Total Fair Value		Level 1		Level 2		Level 3		Total Fair Value
Assets:
Derivatives - foreign exchange contracts	$	—	$	0.1	$	—	$	0.1	$	—	$	—	$	—	$	—
Liabilities:
Derivatives - foreign exchange contracts	$	—	$	2.9	$	—	$	2.9	$	—	$	2.5	$	—	$	2.5

Valuation Technique - The Company’s derivative assets and liabilities include foreign exchange contract derivatives that are measured at fair value using internal models based on observable market inputs such as forward rates and interest rates. Based on these inputs, the derivatives are classified within Level 2 of the valuation hierarchy.

Page 26

The carrying value of the Company’s financial assets and liabilities, including cash and cash equivalents, accounts receivable, accounts payable and short-term loans payable approximate fair value, without being discounted, due to the short periods during which these amounts are outstanding. Long-term debt rates currently available to the Company for debt with similar terms and remaining maturities are used to estimate the fair value for debt issues that are not quoted on an exchange. The estimated fair value of long-term debt is measured using Level 2 inputs and was $830.0 million and $815.2 million at March 31, 2015 and December 31, 2014, respectively.

Note 14 - Restructuring

Repositioning Actions

The Company recorded pre-tax restructuring charges of $18.9 million in 2014, which included $18.7 million of severance and other cash-related restructuring costs and $0.2 million of non-cash restructuring costs related to asset write-downs. The $18.7 million of severance and other cash-related restructuring costs included $4.6 million related to the consolidation of a facility in the U.K. in the Fluid Handling segment, $7.8 million primarily related to the consolidation of a facility in Europe in the Fluid Handling segment and $6.3 million associated with certain facility consolidation activities in the Aerospace & Electronics segment. These charges included severance and move costs related to the transfer of certain manufacturing operations. The Company expects these repositioning actions to result in workforce reductions of approximately 320 employees, or about 3% of the Company’s global workforce.

During the three months ended March 31, 2015, the Company recorded pre-tax restructuring charges of $0.3 million which included $0.5 million related to severance costs and $0.2 million of net restructuring gain driven by the sale of assets of a consolidated facility.

The following table summarizes the accrual balances related to these cash-related restructuring charges:



(in millions)	Balance at December 31, 2014		Expense		Utilization			Balance at March 31, 2015
Fluid Handling
Severance	$	10.7	$	—	$	(2.6	)	$	8.0
Other	—		—		—			—
Total Fluid Handling	$	10.7	$	—	$	(2.6	)	$	8.0

Aerospace & Electronics
Severance	$	1.9	$	0.5	$	(1.1	)	$	1.3
Other	0.5		—		—			0.5
Total Aerospace & Electronics	$	2.4	$	0.5	$	(1.1	)	$	1.8
Total Restructuring	$	13.1	$	0.5	$	(3.8	)	$	9.9

Related to the 2014 repositioning actions, in 2014, the Company recorded $2.6 million and $1.2 million for additional costs incurred as a direct result of the facility consolidations within the Fluid Handling segment and Aerospace & Electronics segments, respectively. During the three months ended March 31, 2015, the Company recorded $2.2 million and $0.1 million within the Fluid Handling segment and Aerospace & Electronics segments, respectively.

The Company expects to incur total restructuring and related charges of approximately $4 million to $6 million in 2015 to complete these actions.

Acquisition-Related Restructuring

In 2014, the Company recorded pre-tax restructuring charges of $10.3 million which included $10.2 million of severance and other cash-related restructuring costs and $0.1 million of non-cash restructuring costs related to asset write-downs related to the December 2013 acquisition of MEI in the Company's Payment & Merchandising Technologies segment. The Company expects these 2014 actions to result in workforce reductions of approximately 240 employees, or less than 2% of the Company’s global workforce.

Page 27

During the three months ended March 31, 2015, the Company recorded pre-tax restructuring charges of $0.2 million of other cash-related restructuring costs related to these actions.

The following table summarizes the accrual balances related to these cash-related restructuring charges:



(in millions)	Balance at December 31, 2014		Expense		Utilization			Balance at March 31, 2015
Payment & Merchandising Technologies
Severance	$	7.0	$	—	$	(1.1	)	$	5.9
Other	—		0.2		(0.2		)	—
Total Restructuring	$	7.0	$	0.2	$	(1.3	)	$	5.9

The Company expects to incur total restructuring and related charges of $6 million to $8 million in 2015 to complete these actions.

Page 28

Part I – Financial Information

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains information about Crane Co., some of which includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements other than historical information or statements about our current condition. You can identify forward-looking statements by the use of terms such as “believes,” “contemplates,” “expects,” “may,” “could,” “should,” “would,” or “anticipates,” other similar phrases, or the negatives of these terms.

Reference herein to “Crane”, “we”, “us”, and, “our” refer to Crane Co. and its subsidiaries unless the context specifically states or implies otherwise. References to “core business” or “core sales” in this report include sales from acquired businesses starting from and after the first anniversary of the acquisition, but exclude currency effects. Amounts in the following discussion are presented in millions, except employee, share and per share data, or unless otherwise stated.

We have based the forward-looking statements relating to our operations on our current expectations, estimates and projections about us and the markets we serve. We caution you that these statements are not guarantees of future performance and involve risks and uncertainties. In addition, we have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. There are a number of other factors that could cause actual results or outcomes to differ materially from those addressed in the forward-looking statements. The factors that we currently believe to be material are detailed in Part II, Item 1A of this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 filed with the Securities and Exchange Commission and are incorporated by reference herein.

Overall

Our sales depend heavily on industries that are cyclical in nature, or are subject to market conditions which may cause customer demand for our products to be volatile. These industries are subject to fluctuations in domestic and international economies as well as to currency fluctuations, inflationary pressures, and commodity costs.

We remain cautious about the global economic outlook and the impact on demand for our products, particularly in our Fluid Handling segment. Specifically, in 2015, we expect a total Company year-over-year sales decline of approximately 4.5%, based on a 4% to 6% adverse impact from foreign exchange and a 0.5% adverse impact from divestitures, partially offset by organic sales growth of 0% to 2%.

In order to better align our cost structure with expected demand and reflecting on our continued focus on productivity, in 2014, we undertook certain repositioning actions at our Fluid Handling and Aerospace & Electronics segments. The costs associated with these repositioning actions were $22.7 million in 2014 and are expected to be $4 million to $6 million in 2015. Savings associated with these repositioning actions are estimated to be $10 million in 2015 and to increase to $19 million on an annual basis in 2016.

In connection with the acquisition of MEI, we recorded $20.1 million of integration and restructuring costs in 2014 and we expect to incur $6 million to $8 million of integration and restructuring costs in 2015. We realized approximately $10 million of acquisition-related synergies in 2014, and we expect an incremental $9 million of synergies in 2015 with a $33 million annualized run rate by the end of 2016.

Fluid Handling

In 2015, in our Fluid Handling segment, we expect a sales decline driven primarily by unfavorable foreign currency translation and, to a lesser extent, a modest core sales decline and the impact of a small divestiture. The expected core sales decline is primarily driven by weakening end market conditions for our core process valve business across the power, refining and chemical vertical end markets. This decline is partially offset by expected improvement in our general industrial process valve end markets, particularly in the United States. With respect to our commercial valve businesses, we expect modest improvement in the Canadian, United Kingdom and Middle East non-residential construction end markets as well as improvement in the municipal markets in United States and United Kingdom. We expect a modest decline in operating profit, driven by the impact of lower sales, the impact of unfavorable foreign exchange, partially offset by productivity, savings from our repositioning initiatives and lower repositioning costs.

Payment & Merchandising Technologies

In 2015, we anticipate Payment & Merchandising Technologies sales to decrease modestly, primarily as a result of unfavorable foreign currency translation which is expected to more than offset an increase in core sales. We expect core sales to increase modestly from higher volume in both the Crane Payment Innovations and Merchandising Systems businesses, partially offset by the impact of the conclusion of a transition services agreement related to a divested product line. We expect an increase in

Page 29

operating profit primarily as a result of the impact of higher core sales, integration synergies and lower integration related costs, partially offset by the impact of unfavorable foreign exchange.

Aerospace & Electronics

In 2015, we expect commercial market conditions in the aerospace industry will remain generally positive. Accordingly, we expect an increase in OEM sales as we benefit from increasing build rates across a broad range of platforms, primarily for large aircraft manufacturers. We remain cautiously optimistic about the aerospace aftermarket. Although we expect defense markets to remain relatively flat, we expect our military sales to increase as a result of initial sales related to a large multi-year contract. Considering all of the foregoing, we expect total segment sales to be modestly higher in 2015. We expect segment operating profit in 2015 to increase reflecting the impact of the higher core sales, improved productivity and savings from 2014 repositioning actions.

Engineered Materials

In 2015, we expect the Engineered Materials segment will show continued improvement in sales, driven by modest growth in RV-related applications and a gradual improvement in building products shipments over the course of the year, partially offset by a decline in sales of our transportation-related products. We expect to be able to leverage this growth together with additional productivity initiatives and to drive operating profit and margin improvement.

Page 30

Results from Operations – Three Month Periods Ended March 31

All comparisons below refer to the first quarter 2015 versus the first quarter 2014, unless otherwise specified.

First quarter of 2015 compared with first quarter of 2014



	First Quarter						Change
(dollars in millions)	2015			2014			$			%
Net sales	$	678.8		$	716.8		$	(38.1	)	(5.3	)%
Operating profit	86.0			81.4			4.6			5.7	%
Restructuring and related charges	2.7			10.0			(7.3		)	(73.0	)%
Acquisition integration related charges	1.6			4.7			(3.1		)	(66.0	)%
Operating margin	12.7		%	11.4		%
Other income (expense):
Interest income	0.5			0.4			0.1			29.6	%
Interest expense	(9.9		)	(9.8		)	(0.1		)	1.1	%
Miscellaneous - net	(0.3		)	(0.2		)	(0.1		)	66.2	%
	(9.7		)	(9.6		)	(0.1		)	1.3	%
Income before income taxes	76.3			71.8			4.5			6.3	%
Provision for income taxes	24.9			22.9			2.0			8.9	%
Net income before allocation to noncontrolling interests	51.3			48.9			2.5			5.0	%
Less: Noncontrolling interest in subsidiaries’ earnings	0.3			0.2			0.1			53.2	%
Net income attributable to common shareholders	$	51.1		$	48.7		$	2.4		4.9	%

First quarter 2015 sales decreased $38.1 million, or 5.3%, compared to the first quarter of 2014. The decline in sales was driven by unfavorable foreign currency translation of $34.1 million, or 4.8%, and the divestiture impact of Crane Water and the completion of a previously disclosed transition services agreement of $5.1 million, or 0.7%, partially offset by core sales growth of $1.2 million, or 0.2%. Net sales related to operations outside the U.S. were 39.1% and 41.7% of total net sales for the quarters ended March 31, 2015 and 2014, respectively.

Operating profit was $86.0 million in the first quarter 2015 compared to $81.4 million in the same period of 2014. The increase in operating profit reflected increases in our Payment & Merchandising Technologies and Engineered Materials segments, partially offset by declines in our Fluid Handling and Aerospace & Electronics segments. Operating profit in the first quarter of 2015 included restructuring and related charges of $2.7 million associated with repositioning actions, as well as integration costs of $1.6 million related to the acquisition of MEI. Operating profit in the first quarter of 2014 included restructuring and related charges of $10.0 million associated with repositioning actions and integration costs of $4.7 million related to the acquisition of MEI. Operating profit margins were 12.7% in the first quarter of 2015, compared to 11.4% in the comparable period in 2014.

Our effective tax rate is affected by a number of items, both recurring and discrete, including the amount of income we earn in different jurisdictions and their respective statutory tax rates, acquisitions and dispositions, changes in the valuation of our deferred tax assets and liabilities, changes in tax laws, regulations and accounting principles, the continued availability of statutory tax credits and deductions, the continued reinvestment of our overseas earnings, and examinations initiated by tax authorities around the world.

Our effective tax rate for the three months ended March 31, 2015 is higher than the prior year’s comparable period primarily due to the unfavorable impacts of recently-enacted Japanese tax reform on certain tax carryforwards and a lower U.S. federal tax benefit on domestic manufacturing activities, partially offset by the favorable impacts of income earned in jurisdictions with lower statutory tax rates and a lower amount of statutorily non-deductible expenses.

Page 31

Segment Results of Operations - Three Month Periods Ended March 31

The following information should be read in conjunction with our condensed consolidated financial statements and related notes.

Fluid Handling



	First Quarter						Change
(dollars in millions)	2015			2014
Sales	$	275.5		$	310.8		$	(35.3	)	(11.4	)%
Operating profit	$	34.3		$	44.5		$	(10.2	)	(23.0	)%
Restructuring and related charges *	$	1.8		$	3.2		$	(1.4	)	(43.8	)%
Operating margin	12.5		%	14.3		%
* The restructuring and related charges are included in operating profit and operating margin.

First quarter 2015 sales decreased $35.3 million from $310.8 million in first quarter 2014 to $275.5 million in 2015, reflecting unfavorable foreign currency translation of $21.9 million, or -7.1%, a core sales decrease of $10.1 million, or -3.2%, and the impact of the divestiture of Crane Water of $3.3 million, or -1.1%. The core sales decline was driven primarily by lower sales in our process valve business, largely from lower sales in the oil and gas end markets, chemical end markets in the Americas and Europe and the power end market in China, partially offset by higher sales in our commercial valve business. Operating profit in the first quarter of 2015 decreased $10.2 million, or -23.0%, primarily reflecting a $6.0 million impact from the lower sales, unfavorable foreign exchange and an unfavorable product mix, partially offset by productivity gains and a $1.4 million decrease in restructuring and related charges.

The Fluid Handling segment backlog was $304 million at March 31, 2015, compared with $311 million at December 31, 2014 and $351 million (which includes $5.4 million pertaining to a business divestiture in June 2014) at March 31, 2014.

Payment & Merchandising Technologies



	First Quarter						Change
(dollars in millions)	2015			2014
Sales	$	171.9		$	169.1		$	2.8		1.7	%
Operating profit	$	21.1		$	7.4		$	13.7		183.6	%
Acquisition, integration and restructuring related charges*	$	1.8		$	12.4		$	(10.6	)	(85.5	)%
Operating margin	12.3		%	4.4		%
* The acquisition, integration and restructuring related charges are included in operating profit and operating margin.

First quarter 2015 sales increased $2.8 million, or 1.7%, reflecting a core sales increase of $16.0 million, or 9.5%, partially offset by unfavorable foreign currency translation of $11.4 million, or -6.7% and the impact of the completion of a previously disclosed transition services agreement related to a divested product line of $1.8 million, or 1.0%. The increase in core sales reflected higher sales in our Crane Payment Innovations and Merchandising Systems business. Sales increased in our Crane Payment Innovations business reflecting higher sales in the vending and transportation end markets, partially offset by lower sales in the retail and financial services vertical market. Sales increased in our Merchandising Systems business reflecting higher sales to certain large bottler customers. Operating profit of $21.1 million increased $13.7 million in 2015 compared to 2014. The operating profit increase was primarily driven by a $10.6 million decrease in acquisition, integration and restructuring related charges, an impact from a $9.3 million impact from higher core sales, as well as acquisition synergies and productivity initiatives, partially offset by an unfavorable product mix and unfavorable foreign exchange.

The Payment & Merchandising Technologies segment backlog was $68 million at March 31, 2015 and December 31, 2014 and $59 million at March 31, 2014.

Page 32

Aerospace & Electronics



	First Quarter						Change
(dollars in millions)	2015			2014
Sales	$	161.6		$	169.0		$	(7.3	)	(4.3	)%
Operating profit	$	30.1		$	32.6		$	(2.5	)	(7.7	)%
Restructuring and related charges*	$	0.9		$	2.8		$	(1.9	)	(67.9	)%
Operating margin	18.6		%	19.3		%
* The restructuring and related charges are included in operating profit and operating margin.

The first quarter 2015 sales decrease of $7.3 million, or 4.3%, reflected a decline in both original equipment manufacturer ("OEM") and aftermarket sales. OEM sales decreased 4.1%, driven primarily by lower shipments to defense related customers. Aftermarket sales decreased 5.9%, driven primarily by the timing of commercial spares shipments and lower retrofit activity. Sales to OEMs and sales to aftermarket customers were 73% and 27%, respectively, of total sales, consistent with the first quarter of the prior year. Operating profit decreased $2.5 million, or 7.7%, in the first quarter of 2015 when compared to the same period in the prior year, driven primarily by a $3.4 million impact from lower volumes and unfavorable product mix, partially offset by a $1.9 million decrease in restructuring and related charges.

The Aerospace & Electronics segment backlog was $446 million at March 31, 2015, compared with $422 million at December 31, 2014 and $398 million at March 31, 2014.

Engineered Materials



	First Quarter						Change
(dollars in millions)	2015			2014
Sales	$	69.7		$	67.9		$	1.8	2.6	%
Operating profit	$	14.3		$	10.8		$	3.5	32.2	%
Operating margin	20.5		%	15.9		%

First quarter 2015 sales of $69.7 million increased $1.8 million, or 2.6%, reflecting higher sales to our recreation vehicle ("RV") and building products customers, partially offset by lower sales to our transportation related customers. We experienced a $2.8 million, or 7.7%, increase in sales to RV manufacturers reflecting higher industry build rates. Sales to our building product customers increased $0.6 million, or 3.3%. Transportation-related sales decreased $1.8 million, or 16.4%, reflecting lower floor and composite wall sales. Operating profit in the first quarter of 2015 increased $3.5 million, or 32.2%, primarily as a result of the impact of higher sales, strong productivity gains and lower raw material costs.

The Engineered Materials segment backlog was $19 million at March 31, 2015, compared with $17 million at December 31, 2014 and March 31, 2014.

Page 33

Liquidity and Capital Resources

Our operating philosophy is to deploy cash provided from operating activities, when appropriate, to provide value to shareholders by reinvesting in existing businesses, by making acquisitions that will complement our portfolio of businesses and by paying dividends and/or repurchasing shares.

Our current cash balance of $297 million, together with cash we expect to generate from future operations and the $373 million available under our CP Program is expected to be sufficient to finance our short- and long-term capital requirements, as well as to fund payments associated with our asbestos and environmental liabilities, restructuring and acquisition integration activities and expected pension contributions. In addition, we believe our credit ratings afford us adequate access to public and private markets for debt. We have borrowings totaling $127 million outstanding under our CP Program. There are no other significant debt maturities coming due until 2018.

We have an estimated liability of $600 million for pending and reasonably anticipated asbestos claims through 2021, and while it is probable that this amount will change and we may incur additional liabilities for asbestos claims after 2021, which additional liabilities may be material, we cannot reasonably estimate the amount of such additional liabilities at this time. Similarly, we have an estimated liability of $76 million related to environmental remediation costs projected through 2022 related to our Goodyear Site and a $6.5 million liability related to environmental remediation costs at our Roseland Site.

Our cash totaled $297 million as of March 31, 2015. Substantially all of this amount is held by our non-U.S. subsidiaries and is subject to additional tax upon repatriation to the U.S. Our intent is to permanently reinvest the earnings of our non-U.S. operations, and current plans do not anticipate that we will need funds generated from our non-U.S. operations to fund our U.S. operations. In the event we were to repatriate the cash balances of our non-U.S. subsidiaries, we would provide for and pay additional U.S. and non-U.S. taxes in connection with such repatriation.

Operating Activities

Cash used for operating activities was $11.6 million in the first three months of 2015, compared to $18.9 million during the same period last year. The improvement resulted primarily from lower working capital requirements and lower net asbestos-related payments. Net asbestos-related payments in the first three months of 2015 and 2014 were $10.7 million and $12.9 million, respectively. We expect to make payments related to asbestos settlement and defense costs, net of related insurance recoveries, of approximately $59 million, and contributions to our defined benefit plans of approximately $17 million.

Investing Activities

Cash flows relating to investing activities consist primarily of cash provided by divestitures of businesses or assets and cash used for acquisitions and capital expenditures. Cash used for investing activities was $8.8 million in the first three months of 2015, compared to cash used for investing activities of $9.2 million in the comparable period of 2014. Capital expenditures are made primarily for increasing capacity, replacing equipment, supporting new product development and improving information systems. We expect our capital expenditures to approximate $50 million in 2015, reflecting anticipated increases in new product development initiatives, primarily in our Aerospace & Electronics and Fluid Handling segments.

Financing Activities

Financing cash flows consist primarily of payments of dividends to shareholders, share repurchases, repayments of indebtedness and proceeds from the issuance of common stock. Cash used for financing activities was $9.9 million during the first three months of 2015 compared to cash provided by financing activities of $9.3 million during the first three months of 2014. The higher levels of cash used for financial activities was primarily due to cash used for open market share repurchases (we repurchased 398,095 shares of our common stock at a cost of $25 million in the first quarter of 2015), partially offset by higher net short-term borrowings.

Page 34

Recent Accounting Pronouncements

Information regarding new accounting pronouncements is included in Note 2 to the Condensed Consolidated Financial Statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in the information called for by this item since the disclosure in our Annual Report on Form 10-K for the year ended December 31, 2014.

Item 4. Controls and Procedures

Disclosure Controls and Procedures. The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this quarterly report. The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports that are filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that the information is accumulated and communicated to the Company’s Chief Executive Officer and Principal Financial Officer to allow timely decisions regarding required disclosure. Based on this evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that these controls are effective as of the end of the period covered by this quarterly report.

Changes in Internal Control over Financial Reporting. During the fiscal quarter ended March 31, 2015, there have been no changes in the Company’s internal control over financial reporting, identified in connection with our evaluation thereof, that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

Page 35

Item 6. Exhibits




Exhibit 31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a)

Exhibit 31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a)

Exhibit 32.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(b) or 15d-14(b)

Exhibit 32.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(b) or 15d-14(b)

Exhibit 101.INS		XBRL Instance Document

Exhibit 101.SCH		XBRL Taxonomy Extension Schema Document

Exhibit 101.CAL		XBRL Taxonomy Calculation Linkbase Document

Exhibit 101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

Exhibit 101.LAB		XBRL Taxonomy Label Linkbase Document

Exhibit 101.PRE		XBRL Taxonomy Presentation Linkbase Document

Notes to Exhibits List:

Attached as Exhibit 101 to this Quarterly Report on Form 10-Q are the following documents formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Operations for the three months ended March 31, 2015 and 2014, respectively; (ii) the Condensed Consolidated Balance Sheets at March 31, 2015 and December 31, 2014; and (iii) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2015 and 2014, respectively. Users of this data are advised that, pursuant to Rule 406T of Regulation S-T, this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is not deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

Page 36

Part II : Other Information

Item 1. Legal Proceedings

Discussion of legal matters is incorporated by reference from Part 1, Item 1, Note 8, “Commitments and Contingencies”, of this Quarterly Report on Form 10-Q, and should be considered an integral part of Part II, Item 1, “Legal Proceedings”.

Item 1A. Risk Factors

Information regarding risk factors appears in in Item 1A of Crane Co.’s Annual Report on Form 10-K for the year ended December 31, 2014. There has been no significant change to the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(a) As previously disclosed in our 2014 Form 10-K, we inadvertently failed to timely file a registration statement on Form S-8 with the Securities and Exchange Commission (“SEC”) regarding the issuance of shares of our common stock pursuant to the Crane Co. 2013 Stock Incentive Plan (the “Plan”), which was approved by shareholders on April 22, 2013. Following discovery of this failure to file, on March 3, 2015, we filed a registration statement on Form S-8 with the SEC to register shares issuable pursuant to the Plan. During the first quarter of 2015 and prior to the filing of the registration statement on Form S-8, a total of 7,898 shares of our common stock were issued upon exercise of stock options granted pursuant to the Plan, and a total of 30,792 shares of our common stock were issued pursuant to the Plan upon the vesting of restricted share units granted thereunder and without any cash consideration being paid, in each instance without registration. We believe that any potential liability resulting from the failure to timely register shares of common stock issuable pursuant to the Plan is not material to our financial condition or results of operations.

(b) Not applicable



	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs
January 1-31	100,446	$	59.71	—	—
February 1-28	297,649	$	63.81	—	—
March 1-31	—	—		—	—
Total January 1 — March 31, 2015	398,095	$	62.78	—	—

The table above only includes the open-market repurchases of our common stock during the three months ended March 31, 2015. We routinely receive shares of our common stock as payment for stock option exercises and the withholding taxes due on stock option exercises and the vesting of restricted stock awards from stock-based compensation program participants.

Item 4. Mine Safety Disclosures

Not applicable

Page 37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



		CRANE CO.
		REGISTRANT

Date
May 7, 2015	By	/s/ Max H. Mitchell
		Max H. Mitchell
		President and Chief Executive Officer

Date	By	/s/ Richard A. Maue
May 7, 2015		Richard A. Maue
		Vice President, Finance and
		Chief Financial Officer

Page 38

Exhibit Index




Exhibit No.		Description

Exhibit 31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a)

Exhibit 31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a)

Exhibit 32.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(b) or 15d-14(b)

Exhibit 32.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(b) or 15d-14(b)

Exhibit 101.INS		XBRL Instance Document

Exhibit 101.SCH		XBRL Taxonomy Extension Schema Document

Exhibit 101.CAL		XBRL Taxonomy Calculation Linkbase Document

Exhibit 101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

Exhibit 101.LAB		XBRL Taxonomy Label Linkbase Document

Exhibit 101.PRE		XBRL Taxonomy Presentation Linkbase Document

Notes to Exhibits List:

Page 39